By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
RESI Boston takes place on June 16, and Life Science Nation is pleased to announce the investor judges participating in this event’s Innovator’s Pitch Challenge (IPC). With more than 50 companies presenting across 14 sessions, the IPC offers life science startups a high-impact opportunity to gain visibility, pitch directly to active investors, and receive valuable feedback in real time.
Each session will feature investor and strategic partner judges with expertise spanning therapeutics, medical devices, diagnostics, digital health, and life science tools. Following every pitch, judges will lead a live Q&A to assess the opportunity and share insights from the investor perspective.
Every IPC company will also have a dedicated table in the RESI Exhibition Hall, making it easy for attendees to connect with founders and learn more.
All registered attendees will be invited to vote online for their favorite companies, and the Top 3 companies will be announced at the end of the day’s cocktail reception. Winners will receive a prize and be featured in an upcoming issue of the LSN newsletter.
Scroll down to see which investors will serve as judges for this year’s IPC:
 John Abeles General Partner Northlea Partners |
 Chris Aleong VP BioIdeations |
 Christina Ansted Sr. Managing Partner RCP Venture Capital |
 Jit Basak Investor Launchit Ventures |
 Jay Batchu Entrepreneur in Residence Xontogeny |
 Randy Berholtz Sr. Advisor Mesa Verde Venture Partners |
 Jeff Berman Managing Partner & Co-Founder Big Tree Innovation Fund |
 Kalyan Chakravarthy Sr. Manager, External Innovation Ipsen S.A. |
 Jo Chaturvedi-Durant Sr. Investor & Venture Partner VU Venture Partners |
 Shailesh Chavan Managing Partner Transatlantic Life Science Venture |
 Nicolas Cindric Partner Yahara Ventures |
 Javier Coindreau General Partner (Boston) Sila B Health Ventures |
 Bettina Ernst Director BERNINA BioInvest |
 Alex Fair Managing Partner Medstartr Capital |
 Dimitra Georganopoulou Managing Director Qral Ventures |
 Serban Georgescu Due Diligence Chair Mass Medical Angels |
 Ken Grise Principal Sixty Degree Capital |
 Marco Gulla Investment Associate Health Technology Holding (HTH) |
 George Hong Investor H Advisor Group |
 Guanghui Hu Venture Partner & CEO Viva BioInnovator |
 Kristin King-Jankiewicz Member & Head of Group Management Boston Harbor Angels |
 Claire Leurent Managing Director AbbVie |
 Vivian Li SA K2 Venture Partners |
 Ali Malihi President Back Bay Group |
 Nune Martiros Sr. Associate Paladin Capital Group |
 Jim McGough Managing Partner Mid Atlantic Bio Angels |
 Ralph Morales III Venture Partner / Executive-in-Residence Aquillius Ventures |
 Jose Navarro Scientific Director & Partner quadraScope Venture Fund |
 Lizzie Ngo Principal Longwood Fund |
 Yoichi Omae BD Director Asahi Intecc USA Inc |
 Soyoung Park General Partner 1004 Venture Partners |
 Chandra Ramanathan VP and Head of External Innovation, Life Sciences Innovation Group Danaher Corporation |
 Nans Rivat VP PACE Healthcare Capital |
 Shreya Sawant Venture Partner Aquillius Ventures |
 Pranav Seshadri Investor T.Rx Capital |
 Jason Shieh Partner/Co-Founder HelixPoint Capital |
 Oliver Sims Investment Manager Octopus Ventures |
 Alex Spicer M&A Associate SERB Pharmaceuticals |
 Sri Sriadibhatla Director, Healthcare Investment Group Ben Franklin Technology Partners of Southern Pennsylvania |
 Isaac Stoner EIR Slater Technology Fund |
 Asad Taherbhoy Angel Investor Angel Star Ventures |
 Wei Tao Board Director & Chair, Bio/Genomics Life Science Angels |
 Vince Wong CEO and President BioCrossroads |
 Chris Yoo General Partner and Managing Director Xcellerant Ventures |
 Doug Zingale Co-Founder & Managing Partner Blue Goose Capital |
 Patrick Cooke, PhD Associate Merck Digital Sciences Studio |
 Samuel Freedman M&A Analyst SERB Pharmaceuticals |
Next Phase Newsletter 
Leave a comment